RNU1-154P

Across TCGA pan-cancer cohorts, RNU1-154P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU1-154P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNU1-154P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-154P expression acts as an unfavorable survival marker, although some lineages such as KIRC and PRAD show a favorable association.

UVM, UCEC, and MESO are the cancer types where RNU1-154P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.037	0.858	<.001	108	view →
UCEC	OS	Tertile	III,IV	0.648	0.854	.001	66	view →
MESO	DFS	Tertile	III,IV	0.043	0.415	<.001	54	view →
KIRC	DFS	Tertile	IV	1.000	0.470	.019	48	view →
BLCA	DFS	Tertile	All	0.119	0.349	.009	36	view →
LAML	DFS	Tertile	All	0.343	0.586	.034	36	view →
LIHC	DFS	Tertile	II,III,IV	0.081	0.463	.017	27	view →
SARC	OS	Tertile	All	0.149	0.778	<.001	18	view →
STAD	OS	Tertile	IV	0.111	0.433	.002	9	view →
PRAD	DFS	Tertile	All	0.970	0.759	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU1-154P–UVM (OS)

Open the UVM breakdown →